Maxim Group analyst Jason Kolbert notes compelling data for Cytori Therapeutics, Inc. (NASDAQ: CYTX) after the company hosted Scleroderma data ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE